Interferon Gamma study on Friedreich’s Ataxia in the US
Interferon Gamma study on Friedreich’s Ataxia in the US, did not meet it's requirements in a recent phase III study; Horizon Pharma have recently announced. This may mean research will have to shift focus elsewhere but fortunately there are other possible therapeutic candidates with potential benefit to people with FA. See the link below for press release issued from Horizon.
Search Ataxia Ireland
People living with an Ataxia benefit enormously from the many services provided by Ataxia Ireland.
Help us to continue helping them